COMMUNIQUÉS West-GlobeNewswire

Wave Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update
29/07/2019
Interim efficacy data from ongoing suvodirsen open-label extension study on track for 4Q 2019 Phase 2/3 DYSTANCE 51 global, placebo-controlled study of suvodirsen initiated First topline data from PRECISION-HD clinical [...]
Silk Road Medical Reports Second Quarter 2019 Financial Results and Raises 2019 Outlook
29/07/2019
SUNNYVALE, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three [...]
Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
29/07/2019
STAMFORD, Conn., July 29, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
Protalix BioTherapeutics to Hold Second Quarter 2019 Financial Results and Corporate Update Conference Call on August 8, 2019
29/07/2019
CARMIEL, Israel, July 29, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX, TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
Livongo Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
29/07/2019
MOUNTAIN VIEW, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced the closing of its initial public offering of 14,590,050 shares of its common stock at a price of $28.00 per [...]
Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
29/07/2019
-- Launched Uncovering Rare Obesity to facilitate diagnosis of rare genetic disorders of obesity -- -- Announced positive opinion by EMA on Orphan Drug Designation for setmelanotide for the treatment of patients with [...]
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results
29/07/2019
-Provides update in ongoing Phase 1/2 clinical trials of CTX001® for patients with severe hemoglobinopathies- -Enrolling in Phase 1/2 clinical trial of CTX110 ™ , targeting CD19+ malignancies- ZUG, Switzerland and [...]
IRADIMED CORPORATION Names Leslie McDonnell as President and Chief Executive Officer
29/07/2019
WINTER SPRINGS, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that its Board of Directors unanimously appointed Leslie McDonnell, to succeed Roger Susi as President and [...]
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
29/07/2019
Orphazyme A/S Company announcement No. 23/2019 Company Registration No. 32266355 Copenhagen, July 29, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients [...]
NM Medical Cannabis Industry First Six Months Up 17% Over Last Year
29/07/2019
Ultra Health leads major economic development with $7.2 million capital expansion project ALBUQUERQUE, N.M., July 29, 2019 (GLOBE NEWSWIRE) -- Ultra Health, New Mexico’s #1 Cannabis Company, leads all 34 cannabis [...]
Test Release: 29.July
29/07/2019
This is a test release and can be ignored. The following is test content: Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce semper convallis porta. Cras finibus tortor gravida vehicula vulputate. Donec [...]
ReFresh Aesthetic Center™ Relaunches CoolSculpting®
29/07/2019
Milwaukee Area’s Top Medical Aesthetic Center’s Team Kick Off the Summer with a Focus on Nonsurgical Fat-Reduction MILWAUKEE, Wis., July 29, 2019 (GLOBE NEWSWIRE) -- As one of the most popular body contouring treatments [...]
L’Agence européenne des médicaments accorde l’accès PRIME au Sepofarsen de ProQR pour l’amaurose congénitale de Leber 10
29/07/2019
Cet accès s'appuie sur une analyse intermédiaire positive des données cliniques et des données précliniques à ce jour La désignation PRIME fournit une voie pour des interactions fréquentes et précoces avec l'EMA visant [...]
Össur hf: Transactions in relation to share buyback program
29/07/2019
Announcement no. 45/2019 29 July 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
Sanofi : Online Availability of Sanofi Group’s Half-Year Financial Report for 2019
29/07/2019
Online Availability of Sanofi Group’s Half-Year Financial Report for 2019 PARIS (France) – July 29, 2019 - Sanofi announces that its half-year financial report for the period ending June 30, 2019 is now available and [...]
Sanofi : Mise en ligne du rapport financier semestriel 2019
29/07/2019
Mise en ligne du rapport financier semestriel 2019 PARIS (France) – 29 juillet 2019 - Sanofi annonce aujourd’hui avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son [...]
Valneva Announces Formation of Scientific Advisory Board
29/07/2019
Valneva Announces Formation of Scientific Advisory Board Saint Herblain (France), July 29, 2019 – Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious [...]
Valneva annonce la création de son Conseil Scientifique
29/07/2019
Valneva annonce la création de son Conseil Scientifique Saint Herblain (France), 29 juillet 2019 – Valneva SE (“Valneva” ou “le Groupe”), société de biotechnologie développant et commercialisant des vaccins contre des [...]
Spineway : Arrangements for availability of the preparatory documents for the General Shareholders’ Meeting of 16 August 2019
29/07/2019
Arrangements for availability of the preparatory documents for the General Shareholders’ Meeting of 16 August 2019 Arrangements for making preparatory documents available The shareholders of Spineway are invited to [...]

Pages